Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01180426. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01518556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06642025. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07233018. IPD Sharing: NO. Countries: 1. Publications: 0.
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
ClinicalTrials.gov study NCT06222580. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04885127. IPD Sharing: NO. Countries: 1. Publications: 0.
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agen
ClinicalTrials.gov study NCT07304011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT
ClinicalTrials.gov study NCT05449899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01027923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03291353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06841952. IPD Sharing: NO. Countries: 1. Publications: 0.
CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06696846. IPD Sharing: YES. Countries: 0. Publications: 0.
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic
ClinicalTrials.gov study NCT06419634. IPD Sharing: NO. Countries: 4. Publications: 0.
Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02381548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06377579. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01332786. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT06672146. IPD Sharing: YES. Countries: 2. Publications: 0.
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00636922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00124644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients
ClinicalTrials.gov study NCT05188326. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.